MBQIF (MindBio Therapeutics) Days Inventory: 0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MBQIF MindBio Therapeutics Corp MBQIF
10 GF Score
Price $0.15
! 1 Warning Sign
View Full Analysis

What is MindBio Therapeutics Days Inventory?

MindBio Therapeutics MBQIF -11.26% 10 Days Inventory is 0.00 as of Mar. 2026. GuruFocus rates MBQIF with a GF Score™ of 10/100. The stock has 1 warning sign investors should review. Among 641 Biotechnology companies, MindBio Therapeutics ranks worse than 156006.08% on this metric.

Days Inventory is also known as Days Sales of Inventory (DSI). MindBio Therapeutics's Average Total Inventories for the three months ended in Mar. 2026 was $0.00 Mil. MindBio Therapeutics's Cost of Goods Sold for the three months ended in Mar. 2026 was $0.00 Mil.

The historical rank and industry rank for MindBio Therapeutics's Days Inventory or its related term are showing as below:

MBQIF's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 182.11
* Ranked among companies with meaningful Days Inventory only.

MindBio Therapeutics's Days Inventory stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


MindBio Therapeutics  (OTCPK:MBQIF) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

MindBio Therapeutics's Inventory Turnover for the three months ended in Mar. 2026 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

MindBio Therapeutics's Inventory to Revenue for the three months ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


MindBio Therapeutics Days Inventory Related Terms


MindBio Therapeutics Days Inventory Historical Data

* Premium members only.

The historical data trend for MindBio Therapeutics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MindBio Therapeutics Days Inventory Chart

MindBio Therapeutics Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Days Inventory
0.00 0.00 0.00 0.00 0.00

MindBio Therapeutics Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MBQIF vs : Days Inventory Comparison

For the Biotechnology subindustry, MindBio Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MindBio Therapeutics Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MindBio Therapeutics's Days Inventory distribution charts can be found below:

* The bar in red indicates where MindBio Therapeutics's Days Inventory falls into.


MBQIF
10GF Score
MindBio Therapeutics Corp MBQIF
Days Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MindBio Therapeutics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

MindBio Therapeutics's Days Inventory for the fiscal year that ended in Jun. 2025 is calculated as

Days Inventory (A: Jun. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Jun. 2024 ) + Total Inventories (A: Jun. 2025 )) / count ) / Cost of Goods Sold (A: Jun. 2025 )*Days in Period
=( (0 + 0) / 1 ) / 0*365
=0 / 0*365
=N/A

MindBio Therapeutics's Days Inventory for the quarter that ended in Mar. 2026 is calculated as:

Days Inventory (Q: Mar. 2026 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2025 ) + Total Inventories (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 4
=0 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 0.00 mean?
MindBio Therapeutics (MBQIF) has a Days Inventory of 0.00 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on MindBio Therapeutics and its competitors. According to the industry distribution chart, MindBio Therapeutics ranks #999999 out of 641 companies in the Biotechnology industry.
Is MindBio Therapeutics' Days Inventory too high?
MindBio Therapeutics' current Days Inventory is 0.00. Based on the distribution chart, MindBio Therapeutics ranks #999999 out of 641 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, MindBio Therapeutics has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does MindBio Therapeutics' Days Inventory compare to ?
According to the Biotechnology industry distribution chart, MindBio Therapeutics ranks #999999 out of 641 companies for Days Inventory. This places MindBio Therapeutics in the lower half of its industry. The industry median Days Inventory is 182.11. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 182.11, based on 641 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on MindBio Therapeutics and its competitors. For the Biotechnology industry, the median Days Inventory is 182.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MindBio Therapeutics's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MindBio Therapeutics stock overvalued right now?
MindBio Therapeutics (MBQIF) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. MindBio Therapeutics' overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For MindBio Therapeutics (MBQIF), the current Days Inventory is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MindBio Therapeutics Business Description

Comparable Companies
Other Exchanges WF60:GermanyMBIO:Canada
Address 91-97 William Steet, Level 4, Melbourne, VIC, AUS, 3000
MindBio Therapeutics Corp is engaged in the research, development, and testing of psychedelic substances as a potential treatment for the management of a broad range of mental health conditions. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough microdosing studies. Geographically, the company's activities take place in Australia.
10GF Score

Get the complete analysis for MBQIF

Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15
Price